New group care model aims to boost HIV prevention in sex workers
NCT ID NCT05929521
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This early-stage study tests a group healthcare model called Centering PrEP+ (C-PrEP+) to help sex workers take and stick with PrEP, a daily pill that prevents HIV. Instead of one-on-one visits, small groups meet with providers for health checks and interactive learning. The study enrolls 24 sex workers and clinic staff to see if this approach is feasible and acceptable.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Group PrEP Care (C-PrEP+)
What this could lead to
If successful, this group care model could make HIV prevention more accessible and effective for sex workers, potentially reducing HIV transmission in this community.
What could go wrong
This is a very early pilot study with only 24 participants, so results may not apply broadly. The intervention is behavioral, not a drug, so its impact on actual HIV rates is uncertain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRE-EXPOSURE PROPHYLAXIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Illinois at Chicago
Chicago, Illinois, 60612, United States